Acne
Actinic Keratosis
Aesthetics
Alopecia
Atopic Dermatitis
Buy-and-Bill
COVID-19
Case-Based Roundtable
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Drug Watch
Eczema
General Dermatology
Hidradenitis Suppurativa
Melasma
NP and PA
Pediatric Dermatology
Pigmentary Disorders
Practice Management
Precision Medicine and Biologics
Prurigo Nodularis
Psoriasis
Psoriatic Arthritis
Rare Disease
Rosacea
Skin Cancer
Vitiligo
Wound Care

Assessing the Use of JAK Inhibitors in Atopic Dermatitis Management : Episode 3

Opinion

Video

March 7, 2025

Selecting Systemic Therapy for Patients with Moderate to Severe Atopic Dermatitis

Author(s):

Lisa Swanson, MD, FAAD,Linda Stein Gold, MD

Panelists discuss how clinicians can choose the most appropriate systemic treatment for moderate to severe atopic dermatitis by evaluating patient characteristics, comorbidities, and therapeutic goals while considering the latest clinical evidence.

Video Player is loading.

Current Time 0:00

Duration 4:55

Loaded: 0%

Stream Type LIVE

Remaining Time 4:55

EP: 1.Determining Atopic Dermatitis Severity and When to Advance to Systemic Therapy

EP: 2.Optimizing Disease Control and AAD Guidelines for Systemic Therapies

Now Viewing

EP: 3.Selecting Systemic Therapy for Patients with Moderate to Severe Atopic Dermatitis

EP: 4.The JAK-STAT Signaling Pathway and Its Role in Atopic Dermatitis

EP: 5.The Impact of JAK Selectivity in Atopic Dermatitis Treatment

EP: 6.Efficacy, Safety, and Role in Therapy of JAK Inhibitors for Atopic Dermatitis

EP: 7.Navigating the Boxed Warning for the JAK Inhibitor Class

EP: 8.Talking to Patients About the Safety of JAK Inhibitors in Atopic Dermatitis

EP: 9.Laboratory Monitoring with Oral JAK Inhibitors

EP: 10.Differentiating Between JAK Inhibitors in Clinical Practice

EP: 11.Overcoming Therapeutic Inertia in a 25-Year-Old Man with Moderate to Severe Atopic Dermatitis

EP: 12.Switching from Biologics to JAK Inhibitors in Nonresponders and Dose Escalation

EP: 13.Navigating Patient Factors When Deciding Treatment for a 38-Year-Old Woman With Severe Atopic Dermatitis

EP: 14.Determining Appropriate Candidates for JAK Inhibitor Therapy

EP: 15.Utility of Head-to-Head Studies in Atopic Dermatitis and Future Research Directions

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!